Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06524167

RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer

Sponsor: Fudan University

View on ClinicalTrials.gov

Summary

This study is a real-world study to observe the role of adjuvant radiotherapy in locally advanced recurrent high-risk thyroid cancer. The study included thyroid cancer that requires adjuvant radiotherapy to increase local control rate, excluding undifferentiated cancer. Local-regional recurrence free survival is the primary endpoint of the study.

Official title: A Real-world Study of Adjuvant Radiotherapy in High Recurrence Risk Locally Advanced Thyroid Cancer

Key Details

Gender

All

Age Range

14 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

80

Start Date

2024-07-02

Completion Date

2031-06-30

Last Updated

2026-02-27

Healthy Volunteers

No

Conditions

Interventions

RADIATION

adjuvant radiotherapy

The patients would receive external radiation therapy within 6 weeks after surgery, using intensity-modulated radiation therapy (IMRT) or volume modulated radiation therapy (VMAT) techniques. 6MV-X-ray irradiation. Conventional segmented irradiation is used, once a day, five times a week, with a segmented dose of 2Gy per dose.

Locations (1)

Fudan University Shanghai Cancer Center

Shanghai, China